Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 289
Selected: 0
NCT IDTitle
NCT01207076AHN-12 Biodistribution in Advanced Leukemia
NCT01885897IL-15 Super Agonist ALT-803 to Treat Relapse Of Hematologic Malignancy After Allogeneic SCT
NCT02999399Glucobrassicin-Brussel Sprout Effect on D10 Phe Metabolism
NCT04629209A Phase II, Open Label Study of ONC201 in Adults With EGFR-low Glioblastoma
NCT01962636Umbilical Cord Blood Transplantation Using a Myeloablative Preparative Regimen for Hematological Diseases
NCT01681875Project 1, Study 1: Investigating the Impact of Nicotine Using Spectrum Cigarettes
NCT03978117Clinical Trial of Two Study Drinks in Detoxification of Environmental Toxicants and Carcinogens
NCT06414278Evaluation of Early Identification of Cognitive Side Effects of Immunotherapy
NCT06692426Trial of Cell Based Therapy for DMD
NCT03934840CASCARA: Castration Sensitive Carboplatin, Cabazitaxel and Abiraterone
NCT00889408DT2219ARL for Relapsed or Refractory CD19 (+), CD 22 (+) B-Lineage Leukemia Or Lymphoma
NCT00262951Chemoradiation in Locally Advanced Pancreatic Cancer
NCT00625092Hyperthermic Intraperitoneal Oxaliplatin for Peritoneal Malignancies
NCT01593618Empowering Cancer Survivors Through Information Technology
NCT00618696Yttrium Y 90 Anti-CD45 Monoclonal Antibody AHN-12 in Treating Patients With Advanced Leukemia
NCT02605421Myeloablative Consolidation Therapy and Tandem Autologous Stem Cell Rescue in Patients With High-Risk Neuroblastoma
NCT02845414Study of CD133KDEL Toxin in the Treatment for Solid Tumors
NCT01677949Clofarabine, Cyclophosphamide and Etoposide for Minimal Residual Disease Positive Acute Leukemia
NCT03609203Improving Self-Efficacy, Resolving Inflammaging Allo HSCT Survivors in Personal Training
NCT01581970Potentiation of Cetuximab by Tregs Depletion With CSA in Advanced Head & Neck Cancer
NCT00818649Bortezomib and Vorinostat in Treating Patients With High-Risk Myelodysplastic Syndrome or Acute Myeloid Leukemia
NCT01400672Imiquimod/Brain Tumor Initiating Cell (BTIC) Vaccine in Brain Stem Glioma
NCT00652899Allogeneic Natural Killer Cells in Patients With Recurrent Ovarian Cancer, Fallopian Tube, and Primary Peritoneal Cancer
NCT02722668UCB Transplant for Hematological Diseases Using a Non Myeloablative Prep
NCT02118285Intraperitoneal Natural Killer Cells and INCB024360 for Recurrent Ovarian, Fallopian Tube, and Primary Peritoneal Cancer
NCT05502302App-Assisted Day Reconstruction to Reduce Logistic Toxicity in Cancer
NCT02670837Study of Cellutome System for Treatment of Individual Lesions in EB Pts
NCT00609739Cytosine Arabinoside and Mitoxantrone for Patients With Juvenile Myelomonocytic Leukemia Receiving Repeat Stem Cell Transplantation
NCT00352118Combination Chemotherapy and Radiation Therapy in Treating Patients With Locally Advanced Head and Neck Cancer
NCT06872333Allo HSCT for High Risk Hemoglobinopathies
NCT07008638Phase I/II Clinical Trial of Proteasome Inhibitor in Combination With CPX-351 for the Treatment of Newly-Diagnosed TP53-mutated Acute Myeloid Leukemia (AML)
NCT00356941Oxaliplatin, Docetaxel, and Radiation Therapy in Treating Patients With Unresectable Stage II/III or Recurrent NSCLC
NCT03981705Assessment of Complete Pathologic Response After Neoadjuvant Chemotherapy for Breast Cancer
NCT02141451ADAM17 Inhibitor/ Rituximab After Auto HCT for DLBCL
NCT00305682Non-Myeloablative Conditioning for Unrelated Donor Umbilical Cord Blood Transplant
NCT02666105Exemestane in Post-Menopausal Women With NSCLC
NCT00167167Donor Lymphocyte Infusion (DLI) for Relapsed (Post Transplant) Leukemia
NCT06377540MT2022-60: Ph 2 Study of Pembro+ BEAM With ASCT for Relapsed Hodgkin Lymphoma
NCT01385423Haploidentical Donor Natural Killer Cell Infusion With IL-15 in Acute Myelogenous Leukemia (AML)
NCT02395822MT2014-25: Haplo NK With SQ IL-15 in Adult Relapsed or Refractory AML Patients
NCT02525029Study of Pregnyl as Adjunct Therapy for High-Risk or Refractory Acute GVHD
NCT00379197Phase II of Naltrexone in Hormone-Refractory Metastatic Breast Cancer
NCT00293293Outcomes in Ovarian Cancer and Fallopian Tube Cancer Patients Using Complementary Alternative Medicine
NCT06544811American Indian Smokefree Native RCT
NCT07153016LEgal Guidance and AdvocaCY for CAREgivers (LEGACY CARE): A Pilot Clinical Trial for Caregivers of Persons With Colorectal Cancer
NCT04090606Tobacco Constituents and Biomarkers
NCT00638547Intrathecal Enzyme Replacement for Hurler Syndrome
NCT00290654Internal Radiation Therapy After Lumpectomy in Treating Women With Ductal Carcinoma in Situ
NCT03297463Radiation Therapy With Combination Immunotherapy for Relapsed/Refractory Metastatic Melanoma
NCT00274846Donor Peripheral Stem Cell Transplant in Treating Patients With Relapsed Acute Myeloid Leukemia